SGK1 and Parkinson disease: In Parkinson disease, SGK1 was found overexpressed and SGK1 knockdown suppressed pro‐inflammatory activities of glia through inhibiting the NLRP3‐ and NFκB‐mediated inflammatory pathways [46].